Showing results (1431-1440 of 1,504) with videos related to

Sort By:
Pageof 151
Familial Cancer|January 8, 2017
Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM studyMaryam Mahmoodi, Tu Nguyen-Dumont, Fleur Hammet, et al.
Familial Cancer|November 11, 2016
Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central EuropeNatalia Bogdanova, Katja Pfeifer, Peter Schürmann, et al.
Familial Cancer|January 26, 2008
Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancerJon G Reichelt, Pål Møller, Ketil Heimdal, et al.
Familial Cancer|February 15, 2014
Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC)Mei Hua Wong, Chuen Seng Tan, Soo Chin Lee, et al.
Familial Cancer|October 4, 2016
Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testingAnna Rohlin, Eva Rambech, Anders Kvist, et al.
Familial Cancer|May 9, 2014
"Would you test your children without their consent?" and other sticky dilemmas in the field of cancer genetic testingKarina L Brierley, Danielle C Bonadies, Anne Moyer, et al.
Familial Cancer|March 22, 2021
Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancerRachel A Pozzar, Fangxin Hong, Niya Xiong, et al.
Familial Cancer|March 23, 2021
A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novelKeivan Majidzadeh-A, Shiva Zarinfam, Nasrin Abdoli, et al.
Familial Cancer|October 26, 2012
Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculinAndrew R Tee, Arnim Pause
Familial Cancer|January 7, 2014
Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational studyLinda Bardram, Thomas V O Hansen, Anne-Marie Gerdes, et al.
Pageof 151